Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of ps

Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of ps

Item

http://www.wikidata.org/entity/Q35176725

Q35176725

about

Cognitive behavioural therapy for psychosis prevention: a systematic review and meta-analysis Comorbid Obsessive-Compulsive Symptoms in Schizophrenia: Insight into Pathomechanisms Facilitates Treatment Endophenotypes in Schizophrenia for the Perinatal Period: Criteria for Validation.Inhibitory interneurons, oxidative stress, and schizophrenia.Prediction and prevention of schizophrenia: what has been achieved and where to go next?[Concept and results of the German Research Network on Schizophrenia].Cannabis use and symptom severity in individuals at ultra high risk for psychosis: a meta-analysis Animal Models of Maternal Immune Activation in Depression Research.Prediction and prevention of the first psychotic episode: new directions and opportunities.The psychosis high-risk state: a comprehensive state-of-the-art review.Attitudes of patients and clinicians in relation to the at-risk state for psychosis.Obsessive-compulsive symptoms in at-risk mental states for psychosis: associations with clinical impairment and cognitive function.Psychotherapy for adolescents and young adults at high risk for psychosis: a systematic review.Evidence-based psychotherapy for the prevention and treatment of first-episode psychosis.Negative schemata about the self and others and paranoid ideation in at-risk states and those with persisting positive symptoms.Altering the course of schizophrenia: progress and perspectives.Prediction and prevention of psychosis: current progress and future tasks.Evaluation of the 'Jumping to conclusions' bias in different subgroups of the at-risk mental state: from cognitive basic symptoms to UHR criteria.Comorbid obsessive-compulsive symptoms in schizophrenia: contributions of pharmacological and genetic factors.Oxidative/Nitrosative stress in psychiatric disorders: are we there yet?The importance of cognitive processes for the integrative treatment of persons with schizophrenia.The usefulness for indicated prevention of severe mental disorders should play a central part in the further development of CBT.[Services for the early recognition of psychoses and bipolar disorders in Germany: inventory survey study].[Prevention of psychotic disorders].Clinical high risk for psychosis: the association between momentary stress, affective and psychotic symptoms.Clinical high risk for psychosis: gender differences in symptoms and social functioning.[Should antipsychotics be used in prodromal stages of schizophrenia to prevent psychosis? Con].

P2860

Q22251382-DD3738F7-2176-4A81-B61F-CC324FB4BAB0 Q27015872-9EDA3446-A3D3-4403-BC66-72A6121E98AA Q30380523-5348CEA9-6096-4555-848B-0A6DDC8A232E Q30455112-15942EA1-47E8-446F-84A4-F3795E83292B Q30473765-91743B09-59B0-4DD3-8D64-54235EA31B9D Q30489053-5D881660-6021-4C94-AA4E-2BA4C0B36576 Q33834127-4385AA09-805F-44DF-A48A-08235618EE05 Q37310541-D9544428-4BC8-46A1-B79A-D9835C7F9BB5 Q37682795-8662BB5D-92EE-4590-A958-0FFE39F5A6AF Q38061036-95A272EA-394C-4B36-AE6C-01C85BAA8BDE Q38114987-7A905EF0-4CB7-480A-8BF1-6429F456F4D1 Q38191255-F41DAD4C-56D7-4BF5-A296-25145CAE17C6 Q38191698-68AFFD75-652F-4315-96C6-A6B481183BEA Q38254790-DEBE8E00-2E75-4FBC-AD71-E1ABF41D2E9A Q38681825-05571107-CF66-48B1-80FD-2401A43BE0BA Q38759421-25166A4D-8442-4552-A714-50AD1CE4F3C5 Q39123249-C4C970B5-E6A6-40F3-AC52-DF5220D6FAFA Q39838892-B4D917F8-78F2-4F68-80D1-FEE536670293 Q42052463-199B00CE-10A1-42A3-B643-DEE8EA9E65B1 Q42792118-14C95B4E-26DD-4D4E-88DA-645C2906AE6A Q42873386-E0539B99-A5FD-43ED-BB09-F682E821F741 Q42973987-8489915A-4D95-4C50-9B27-28F779487C50 Q44134766-16D3E262-A305-4A2F-87C4-182E4930A981 Q44420778-BA386C96-8640-4116-88DF-73041D0E64A3 Q47785426-9822A672-9641-4350-943D-5823EEFD0F46 Q48088952-F216CB9D-733B-4B6E-9432-CB72E6B1B425 Q52860745-012ACCF2-B39F-4CDA-9E7D-A3749B72E817

P2860

Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of ps

Item

http://www.wikidata.org/entity/Q35176725

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu